We are live on ! Find out more
DMIIR

Drugs Made In America Acquisition II Corp Right
DMIIR

61 hedge funds and large institutions have $3.29M invested in Drugs Made In America Acquisition II Corp Right in 2026 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more funds holding

Funds holding: 5761 (+4)

1% more capital invested

Capital invested by funds: $3.25M → $3.29M (+$35.1K)

25% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 8

Holders
61
Holders Change
+4
Holders Change %
+7.02%
% of All Funds
0.74%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
6
Reduced
8
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
TAL
26
TIG Advisors LLC
New York
$40K +$42.8K +500,000 New
WAM
27
Wolverine Asset Management
Illinois
$39.9K -$316 -3,700 -0.7%
HI
28
HBK Investments
Texas
$36.4K
MC
29
Meteora Capital
Florida
$36.3K -$2.3K -26,903 -6%
WA
30
Whitebox Advisors
Minnesota
$36K
SCM
31
Shaolin Capital Management
Florida
$32.2K +$2.34K +27,368 +7%
RCM
32
Rivernorth Capital Management
Florida
$32K
WC
33
Wealthspring Capital
New York
$32K -$191 -2,230 -0.6%
COPPSERS
34
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$32K
HCM
35
Heights Capital Management
California
$30.4K -$964 -11,271 -3%
KC
36
Kryger Capital
United Kingdom
$28.6K -$714 -8,354 -2%
BNP Paribas Financial Markets
37
BNP Paribas Financial Markets
France
$27.9K
LPC
38
Lineage Point Capital
Florida
$26.4K
PC
39
Periscope Capital
Ontario, Canada
$24K
AGM
40
Alpine Global Management
New York
$24K
CS
41
Clear Street
New York
$23.8K +$13.2K +154,745 +108%
BFM
42
Boothbay Fund Management
New York
$20.4K -$1.17K -13,666 -5%
KPF
43
K2 Principal Fund
Ontario, Canada
$20K
MTCM
44
Mint Tower Capital Management
Netherlands
$20K
KC
45
Kepos Capital
New York
$15K +$16.1K +188,400 New
Verition Fund Management
46
Verition Fund Management
Connecticut
$14.5K
GCIA
47
Gabelli & Co Investment Advisers
New York
$14.4K
GF
48
Gabelli Funds
New York
$12.9K
JP Morgan Chase
49
JP Morgan Chase
New York
$11.5K
DAM
50
DLD Asset Management
New York
$8.98K

DMIIR Hedge Fund Activity: Q2 2026 in Review

61 of the 8,279 institutional investors tracked by Wall St. Rank reported a position in Drugs Made In America Acquisition II Corp Right (DMIIR) for Q2 2026, worth a combined $3.29M — up 1.1% from $3.25M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new DMIIR positions and 0 closed out — a net gain of 4 holders — while 6 added to existing stakes and 8 trimmed.

The largest buyer was TIG Advisors LLC, opening a new position worth an estimated $42.8K. The largest seller was Hudson Bay Capital Management, cutting an estimated $33.5K.

  • 61 institutional investors held Drugs Made In America Acquisition II Corp Right (DMIIR) as of Q2 2026, up from 57 in Q1 2026.
  • Funds reported $3.29M of Drugs Made In America Acquisition II Corp Right stock for Q2 2026, up 1.1% quarter-over-quarter.
  • 4 funds opened new Drugs Made In America Acquisition II Corp Right positions in Q2 2026 and 0 closed out, a net change of +4 holders.
  • The largest Drugs Made In America Acquisition II Corp Right buyer in Q2 2026 was TIG Advisors LLC, an estimated $42.8K added.
  • The largest Drugs Made In America Acquisition II Corp Right seller in Q2 2026 was Hudson Bay Capital Management, an estimated $33.5K sold.

Based on aggregated 13F filings for Q2 2026.